Dubai – Masaader News
Researchers in Hong Kong may have found a winning combination by a triple combination therapy, which shows promise for COVID-19 patients with less severe illnesses, according to ABC News.
According to the report, Early data shows that a triple antiviral therapy may be safe and effective in treating patients with mild to moderate cases of COVID-19, according to a study published Friday in Lancet.
Researchers say: ” All three drugs used in the study are already approved to treat other illnesses. Interferon beta 1b is a drug commonly used to treat multiple sclerosis, lopinavir-ritonavir is an anti-retroviral medication used to treat HIV and ribavirin is commonly used to treat hepatitis C”.